{"transactions":[{"id":1332842,"issuer":{"id":85102,"kind":"organization","name":"LUMOS PHARMA, INC.","symbol":"(LUMO)"},"owners":[{"id":85104,"kind":"person","name":"Schuchart Aaron","position":1,"cik":"0001709258","reported_name":"Schuchart Aaron","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Business Officer"}}],"security":"Stock Option (Right to Buy)","published_at":"2024-12-13T21:31:09.000Z","date":"2024-12-12","kind":"disposition_to_issuer","planned":false,"acquired":false,"shares":8500,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F3","text":"Represents an out-of-money option that was cancelled without any cash payment or issuance of CVRs being made in respect thereof pursuant to the Merger Agreement."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"Represents an out-of-money option that was cancelled without any cash payment or issuance of CVRs being made in respect thereof pursuant to the Merger Agreement."}],"balance_after":0,"derivative":{"exercise_price":17.35,"expiration_date":"2031-01-31","underlying":"Common Stock","underlying_shares":8500},"source":{"system":"sec-edgar","filing":"0001126234-24-000114","document":"wk-form4_1734143462.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":7,"url":"https://www.sec.gov/Archives/edgar/data/1126234/000112623424000114/wk-form4_1734143462.xml","form_type":"4"}},{"id":1332841,"issuer":{"id":85102,"kind":"organization","name":"LUMOS PHARMA, INC.","symbol":"(LUMO)"},"owners":[{"id":85104,"kind":"person","name":"Schuchart Aaron","position":1,"cik":"0001709258","reported_name":"Schuchart Aaron","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Business Officer"}}],"security":"Stock Option (Right to Buy)","published_at":"2024-12-13T21:31:09.000Z","date":"2024-12-12","kind":"disposition_to_issuer","planned":false,"acquired":false,"shares":7805,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F3","text":"Represents an out-of-money option that was cancelled without any cash payment or issuance of CVRs being made in respect thereof pursuant to the Merger Agreement."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"Represents an out-of-money option that was cancelled without any cash payment or issuance of CVRs being made in respect thereof pursuant to the Merger Agreement."}],"balance_after":0,"derivative":{"exercise_price":10.13,"expiration_date":"2031-05-31","underlying":"Common Stock","underlying_shares":7805},"source":{"system":"sec-edgar","filing":"0001126234-24-000114","document":"wk-form4_1734143462.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":6,"url":"https://www.sec.gov/Archives/edgar/data/1126234/000112623424000114/wk-form4_1734143462.xml","form_type":"4"}},{"id":1332840,"issuer":{"id":85102,"kind":"organization","name":"LUMOS PHARMA, INC.","symbol":"(LUMO)"},"owners":[{"id":85104,"kind":"person","name":"Schuchart Aaron","position":1,"cik":"0001709258","reported_name":"Schuchart Aaron","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Business Officer"}}],"security":"Stock Option (Right to Buy)","published_at":"2024-12-13T21:31:09.000Z","date":"2024-12-12","kind":"disposition_to_issuer","planned":false,"acquired":false,"shares":12000,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F3","text":"Represents an out-of-money option that was cancelled without any cash payment or issuance of CVRs being made in respect thereof pursuant to the Merger Agreement."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"Represents an out-of-money option that was cancelled without any cash payment or issuance of CVRs being made in respect thereof pursuant to the Merger Agreement."}],"balance_after":0,"derivative":{"exercise_price":10.02,"expiration_date":"2032-01-31","underlying":"Common Stock","underlying_shares":12000},"source":{"system":"sec-edgar","filing":"0001126234-24-000114","document":"wk-form4_1734143462.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1126234/000112623424000114/wk-form4_1734143462.xml","form_type":"4"}},{"id":1332839,"issuer":{"id":85102,"kind":"organization","name":"LUMOS PHARMA, INC.","symbol":"(LUMO)"},"owners":[{"id":85104,"kind":"person","name":"Schuchart Aaron","position":1,"cik":"0001709258","reported_name":"Schuchart Aaron","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Business Officer"}}],"security":"Stock Option (Right to Buy)","published_at":"2024-12-13T21:31:09.000Z","date":"2024-12-12","kind":"disposition_to_issuer","planned":false,"acquired":false,"shares":45000,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F3","text":"Represents an out-of-money option that was cancelled without any cash payment or issuance of CVRs being made in respect thereof pursuant to the Merger Agreement."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"Represents an out-of-money option that was cancelled without any cash payment or issuance of CVRs being made in respect thereof pursuant to the Merger Agreement."}],"balance_after":0,"derivative":{"exercise_price":9.06,"expiration_date":"2030-05-05","underlying":"Common Stock","underlying_shares":45000},"source":{"system":"sec-edgar","filing":"0001126234-24-000114","document":"wk-form4_1734143462.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1126234/000112623424000114/wk-form4_1734143462.xml","form_type":"4"}},{"id":1332838,"issuer":{"id":85102,"kind":"organization","name":"LUMOS PHARMA, INC.","symbol":"(LUMO)"},"owners":[{"id":85104,"kind":"person","name":"Schuchart Aaron","position":1,"cik":"0001709258","reported_name":"Schuchart Aaron","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Business Officer"}}],"security":"Stock Option (Right to Buy)","published_at":"2024-12-13T21:31:09.000Z","date":"2024-12-12","kind":"disposition_to_issuer","planned":false,"acquired":false,"shares":12000,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F2","text":"This option was cancelled pursuant to the Merger Agreement in exchange for (i) an amount in cash equal to the product of (x) the total number of shares underlying such option multiplied by (y) the excess of the Cash Amount over the applicable exercise price per share and (ii) one CVR for each share underlying such in-the-money option."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"This option was cancelled pursuant to the Merger Agreement in exchange for (i) an amount in cash equal to the product of (x) the total number of shares underlying such option multiplied by (y) the excess of the Cash Amount over the applicable exercise price per share and (ii) one CVR for each share underlying such in-the-money option."}],"balance_after":0,"derivative":{"exercise_price":2.84,"expiration_date":"2034-03-31","underlying":"Common Stock","underlying_shares":12000},"source":{"system":"sec-edgar","filing":"0001126234-24-000114","document":"wk-form4_1734143462.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1126234/000112623424000114/wk-form4_1734143462.xml","form_type":"4"}},{"id":1332837,"issuer":{"id":85102,"kind":"organization","name":"LUMOS PHARMA, INC.","symbol":"(LUMO)"},"owners":[{"id":85104,"kind":"person","name":"Schuchart Aaron","position":1,"cik":"0001709258","reported_name":"Schuchart Aaron","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Business Officer"}}],"security":"Stock Option (Right to Buy)","published_at":"2024-12-13T21:31:09.000Z","date":"2024-12-12","kind":"disposition_to_issuer","planned":false,"acquired":false,"shares":12000,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F2","text":"This option was cancelled pursuant to the Merger Agreement in exchange for (i) an amount in cash equal to the product of (x) the total number of shares underlying such option multiplied by (y) the excess of the Cash Amount over the applicable exercise price per share and (ii) one CVR for each share underlying such in-the-money option."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"This option was cancelled pursuant to the Merger Agreement in exchange for (i) an amount in cash equal to the product of (x) the total number of shares underlying such option multiplied by (y) the excess of the Cash Amount over the applicable exercise price per share and (ii) one CVR for each share underlying such in-the-money option."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F2","text":"This option was cancelled pursuant to the Merger Agreement in exchange for (i) an amount in cash equal to the product of (x) the total number of shares underlying such option multiplied by (y) the excess of the Cash Amount over the applicable exercise price per share and (ii) one CVR for each share underlying such in-the-money option."}],"balance_after":0,"derivative":{"exercise_price":3.52,"underlying":"Common Stock","underlying_shares":12000},"source":{"system":"sec-edgar","filing":"0001126234-24-000114","document":"wk-form4_1734143462.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1126234/000112623424000114/wk-form4_1734143462.xml","form_type":"4"}},{"id":1332836,"issuer":{"id":85102,"kind":"organization","name":"LUMOS PHARMA, INC.","symbol":"(LUMO)"},"owners":[{"id":85104,"kind":"person","name":"Schuchart Aaron","position":1,"cik":"0001709258","reported_name":"Schuchart Aaron","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Business Officer"}}],"security":"Common Stock","published_at":"2024-12-13T21:31:09.000Z","date":"2024-12-12","kind":"disposition_to_issuer","planned":false,"acquired":false,"shares":8179,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Disposed of pursuant to that certain Agreement and Plan of Merger, dated October 22, 2024, by and between the Issuer, DPV Parent, Inc., DPV MergerSub, Inc. and Double Point Ventures LLC (\"DPV\") (the \"Merger Agreement\") in exchange for (i) $4.25 in cash per share (the \"Cash Amount\"), plus (ii) one non-transferable contingent value right (\"CVR\") per share.  Each restricted stock unit (\"RSU\") was cancelled and will receive the Cash Amount plus one CVR per RSU."}],"balance_after":0,"source":{"system":"sec-edgar","filing":"0001126234-24-000114","document":"wk-form4_1734143462.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1126234/000112623424000114/wk-form4_1734143462.xml","form_type":"4"}},{"id":1550726,"issuer":{"id":85102,"kind":"organization","name":"LUMOS PHARMA, INC.","symbol":"(LUMO)"},"owners":[{"id":85104,"kind":"person","name":"Schuchart Aaron","position":1,"cik":"0001709258","reported_name":"Schuchart Aaron","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Business Officer"}}],"security":"Stock Option (Right to Buy)","published_at":"2024-04-03T17:09:36.000Z","date":"2024-04-01","kind":"grant","planned":false,"acquired":true,"shares":12000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F5","text":"Grant to the Reporting Person of a stock option under the Plan. The option vests and becomes exercisable in a series of 48 successive equal monthly installments beginning on May 1, 2024, provided that at the relevant vesting dates the Reporting Person's continuous service to the Issuer has not been terminated as defined in or as determined under the Plan. The option expires ten years after the date of grant."}],"balance_after":12000,"derivative":{"exercise_price":2.84,"expiration_date":"2034-03-31","underlying":"Common Stock","underlying_shares":12000},"source":{"system":"sec-edgar","filing":"0001126234-24-000034","document":"wk-form4_1712178560.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1126234/000112623424000034/wk-form4_1712178560.xml","form_type":"4"}},{"id":1550725,"issuer":{"id":85102,"kind":"organization","name":"LUMOS PHARMA, INC.","symbol":"(LUMO)"},"owners":[{"id":85104,"kind":"person","name":"Schuchart Aaron","position":1,"cik":"0001709258","reported_name":"Schuchart Aaron","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Business Officer"}}],"security":"Common Stock","published_at":"2024-04-03T17:09:36.000Z","date":"2024-04-01","kind":"grant","planned":false,"acquired":true,"shares":1000,"price":2.84,"value":2840.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents shares issued as restricted stock units (\"RSUs\") under the Issuer's 2009 Equity Incentive Plan (the \"Plan\") that were received as an award, for no consideration.  The RSUs vest in a series of four successive annual installments beginning on April 1, 2025, provided in each case that the Reporting Person's continuous service to the Issuer has not been terminated as defined in or as determined under the Plan."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Includes 174 RSUs granted under the Plan.  The RSUs will vest, and shares will be delivered to the Reporting Person on February 1, 2025, provided that the Reporting Person's continuous service to the Issuer has not been terminated as defined in or as determined under the Plan."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F3","text":"Includes 500 RSUs granted under the Plan.  The RSUs will vest, and shares will be delivered to the Reporting Person in a series of two successive annual installments with the next installment occurring on February 1, 2025, provided in each case that the Reporting Person's continuous service to the Issuer has not been terminated as defined in or as determined under the Plan."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F4","text":"Includes 750 RSUs granted under the Plan.  The RSUs will vest, and shares will be delivered to the Reporting Person in a series of three successive annual installments with the next installment occurring on February 1, 2025, provided in each case that the Reporting Person's continuous service to the Issuer has not been terminated as defined in or as determined under the Plan."}],"balance_after":6679,"source":{"system":"sec-edgar","filing":"0001126234-24-000034","document":"wk-form4_1712178560.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1126234/000112623424000034/wk-form4_1712178560.xml","form_type":"4"}},{"id":1659435,"issuer":{"id":85102,"kind":"organization","name":"LUMOS PHARMA, INC.","symbol":"(LUMO)"},"owners":[{"id":85104,"kind":"person","name":"Schuchart Aaron","position":1,"cik":"0001709258","reported_name":"Schuchart Aaron","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Business Officer"}}],"security":"Common Stock","published_at":"2024-02-05T17:52:48.000Z","date":"2024-02-01","kind":"tax_withholding","planned":false,"acquired":false,"shares":202,"price":3.01,"value":608.02,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents shares of Common Stock withheld by the Issuer in satisfaction of its tax withholding obligation with respect to the vesting of 674 previously reported restricted stock units (\"RSUs\") granted to the Reporting Person."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Includes 174 RSUs previously reported as holdings of the Reporting Person granted under the Plan.  The RSUs will vest, and shares will be delivered to the Reporting Person on February 1, 2025, provided that the Reporting Person's continuous service to the Issuer has not been terminated as defined in or as determined under the Plan."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F3","text":"Includes 500 RSUs previously reported as holdings of the Reporting Person granted under the Plan.  The RSUs will vest, and shares will be delivered to the Reporting Person in a series of two successive annual installments with the next installment occurring on February 1, 2025, provided in each case that the Reporting Person's continuous service to the Issuer has not been terminated as defined in or as determined under the Plan."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F4","text":"Includes 750 RSUs previously reported as holdings of the Reporting Person granted under the Plan.  The RSUs will vest, and shares will be delivered to the Reporting Person in a series of three successive annual installments with the next installment occurring on February 1, 2025, provided in each case that the Reporting Person's continuous service to the Issuer has not been terminated as defined in or as determined under the Plan."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F5","text":"Includes 500 shares acquired under the Lumos Pharma, Inc. 2010 Employee Stock Purchase Plan on December 31, 2023."}],"balance_after":5679,"source":{"system":"sec-edgar","filing":"0001126234-24-000013","document":"wk-form4_1707173555.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1126234/000112623424000013/wk-form4_1707173555.xml","form_type":"4"}},{"id":2033600,"issuer":{"id":85102,"kind":"organization","name":"LUMOS PHARMA, INC.","symbol":"(LUMO)"},"owners":[{"id":85104,"kind":"person","name":"Schuchart Aaron","position":1,"cik":"0001709258","reported_name":"Schuchart Aaron","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Business Officer"}}],"security":"Stock Option (Right to Buy)","published_at":"2023-02-03T17:04:45.000Z","date":"2023-02-01","kind":"grant","acquired":true,"shares":12000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F6","text":"Grant to the Reporting Person of a stock option under the Plan.  50% of the option vests and becomes exercisable in a series of 48 successive equal monthly installments beginning on March 1, 2023, provided that at the relevant vesting dates the Reporting Person's continuous service to the Issuer has not been terminated as defined in or as determined under the Plan.  The option expires ten years after the Date of Grant."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F7","text":"The remaining 50% of the stock options vest and become exercisable in 3 substantially equal tranches on the first of the month following an increase of closing stock price, as defined as the closing stock price on Nasdaq Stock Market by at least 50%, 100% and 150%, respectively, above the closing stock on December 31, 2022, when measured over 30 consecutive calendar days, provided such increase occurs within two years of the Date of Grant, otherwise such options shall be cancelled."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F8","text":"Unless otherwise disclosed, the option expires ten years after the date of grant."}],"balance_after":12000,"derivative":{"exercise_price":3.52,"underlying":"Common Stock","underlying_shares":12000},"source":{"system":"sec-edgar","filing":"0001126234-23-000018","document":"wf-form4_167546185913841.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1126234/000112623423000018/wf-form4_167546185913841.xml","form_type":"4"}},{"id":2033599,"issuer":{"id":85102,"kind":"organization","name":"LUMOS PHARMA, INC.","symbol":"(LUMO)"},"owners":[{"id":85104,"kind":"person","name":"Schuchart Aaron","position":1,"cik":"0001709258","reported_name":"Schuchart Aaron","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Business Officer"}}],"security":"Common Stock","published_at":"2023-02-03T17:04:45.000Z","date":"2023-02-01","kind":"tax_withholding","acquired":false,"shares":104,"price":3.52,"value":366.08,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F5","text":"Represents shares of Common Stock withheld by the Issuer in satisfaction of its tax withholding obligation with respect to the vesting of 424 previously reported restricted stock units (\"RSUs\") granted to the Reporting Person."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Includes 348 RSUs previously reported as holdings of the Reporting Person granted under the Plan.  The RSUs will vest, and shares will be delivered to the Reporting Person in a series of two successive annual installments with the next installment occurring on February 1, 2024, provided in each case that the Reporting Person's continuous service to the Issuer has not been terminated as defined in or as determined under the Plan."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F3","text":"Includes 750 RSUs previously reported as holdings of the Reporting Person granted under the Plan.  The RSUs will vest, and shares will be delivered to the Reporting Person in a series of three successive annual installments with the next installment occurring on February 1, 2024, provided in each case that the Reporting Person's continuous service to the Issuer has not been terminated as defined in or as determined under the Plan."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F4","text":"Includes 500 shares acquired under the Lumos Pharma, Inc. 2010 Employee Stock Purchase Plan on December 31, 2022."}],"balance_after":5381,"source":{"system":"sec-edgar","filing":"0001126234-23-000018","document":"wf-form4_167546185913841.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1126234/000112623423000018/wf-form4_167546185913841.xml","form_type":"4"}},{"id":2033598,"issuer":{"id":85102,"kind":"organization","name":"LUMOS PHARMA, INC.","symbol":"(LUMO)"},"owners":[{"id":85104,"kind":"person","name":"Schuchart Aaron","position":1,"cik":"0001709258","reported_name":"Schuchart Aaron","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Business Officer"}}],"security":"Common Stock","published_at":"2023-02-03T17:04:45.000Z","date":"2023-02-01","kind":"grant","acquired":true,"shares":1000,"price":3.52,"value":3520.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents shares issued as restricted stock units (\"RSUs\") under the Issuer's 2009 Equity Incentive Plan, as amended, (the \"Plan\") that were received as an award, for no consideration.  The RSUs vest in a series of four successive annual installments beginning on February 1, 2024, provided in each case that the Reporting Person's continuous service to the Issuer has not been terminated as defined in or as determined under the Plan."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Includes 348 RSUs previously reported as holdings of the Reporting Person granted under the Plan.  The RSUs will vest, and shares will be delivered to the Reporting Person in a series of two successive annual installments with the next installment occurring on February 1, 2024, provided in each case that the Reporting Person's continuous service to the Issuer has not been terminated as defined in or as determined under the Plan."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F3","text":"Includes 750 RSUs previously reported as holdings of the Reporting Person granted under the Plan.  The RSUs will vest, and shares will be delivered to the Reporting Person in a series of three successive annual installments with the next installment occurring on February 1, 2024, provided in each case that the Reporting Person's continuous service to the Issuer has not been terminated as defined in or as determined under the Plan."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F4","text":"Includes 500 shares acquired under the Lumos Pharma, Inc. 2010 Employee Stock Purchase Plan on December 31, 2022."}],"balance_after":5485,"source":{"system":"sec-edgar","filing":"0001126234-23-000018","document":"wf-form4_167546185913841.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1126234/000112623423000018/wf-form4_167546185913841.xml","form_type":"4"}},{"id":2414539,"issuer":{"id":85102,"kind":"organization","name":"LUMOS PHARMA, INC.","symbol":"(LUMO)"},"owners":[{"id":85104,"kind":"person","name":"Schuchart Aaron","position":1,"cik":"0001709258","reported_name":"Schuchart Aaron","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Business Officer"}}],"security":"Stock Option (Right to Buy)","published_at":"2022-02-03T16:37:21.000Z","date":"2022-02-01","kind":"grant","acquired":true,"shares":12000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"Grant to the Reporting Person of a stock option under the Plan. The option vests and becomes exercisable in a series of 48 successive equal monthly installments beginning on March 1, 2022, provided that at the relevant vesting dates the Reporting Person's continuous service to the Issuer has not been terminated as defined in or as determined under the Plan. The option expires ten years after the date of grant."}],"balance_after":12000,"derivative":{"exercise_price":10.02,"expiration_date":"2032-01-31","underlying":"Common Stock","underlying_shares":12000},"source":{"system":"sec-edgar","filing":"0001126234-22-000012","document":"wf-form4_164392421135990.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1126234/000112623422000012/wf-form4_164392421135990.xml","form_type":"4"}},{"id":2414538,"issuer":{"id":85102,"kind":"organization","name":"LUMOS PHARMA, INC.","symbol":"(LUMO)"},"owners":[{"id":85104,"kind":"person","name":"Schuchart Aaron","position":1,"cik":"0001709258","reported_name":"Schuchart Aaron","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Business Officer"}}],"security":"Common Stock","published_at":"2022-02-03T16:37:21.000Z","date":"2022-02-01","kind":"tax_withholding","acquired":false,"shares":52,"price":10.02,"value":521.04,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F3","text":"Represents shares of Common Stock withheld by the Issuer in satisfaction of its tax withholding obligation with respect to the vesting of 173 previously reported restricted stock units (\"RSUs\") granted to the Reporting Person."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Includes 522 RSUs previously reported as holdings of the Reporting Person granted under the Plan.  The RSUs will vest, and shares will be delivered to the Reporting Person in a series of three successive annual installments with the next installment occurring on February 1, 2023, provided in each case that the Reporting Person's continuous service to the Issuer has not been terminated as defined in or as determined under the Plan."}],"balance_after":3985,"source":{"system":"sec-edgar","filing":"0001126234-22-000012","document":"wf-form4_164392421135990.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1126234/000112623422000012/wf-form4_164392421135990.xml","form_type":"4"}},{"id":2414537,"issuer":{"id":85102,"kind":"organization","name":"LUMOS PHARMA, INC.","symbol":"(LUMO)"},"owners":[{"id":85104,"kind":"person","name":"Schuchart Aaron","position":1,"cik":"0001709258","reported_name":"Schuchart Aaron","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Business Officer"}}],"security":"Common Stock","published_at":"2022-02-03T16:37:21.000Z","date":"2022-02-01","kind":"grant","acquired":true,"shares":1000,"price":10.02,"value":10020.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents shares issued as restricted stock units (\"RSUs\") under the Issuer's 2009 Equity Incentive Plan, as amended, (the \"Plan\") that were received as an award, for no consideration.  The RSUs vest in a series of four successive annual installments beginning on February 1, 2023, provided in each case that the Reporting Person's continuous service to the Issuer has not been terminated as defined in or as determined under the Plan."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Includes 522 RSUs previously reported as holdings of the Reporting Person granted under the Plan.  The RSUs will vest, and shares will be delivered to the Reporting Person in a series of three successive annual installments with the next installment occurring on February 1, 2023, provided in each case that the Reporting Person's continuous service to the Issuer has not been terminated as defined in or as determined under the Plan."}],"balance_after":4037,"source":{"system":"sec-edgar","filing":"0001126234-22-000012","document":"wf-form4_164392421135990.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1126234/000112623422000012/wf-form4_164392421135990.xml","form_type":"4"}},{"id":2604054,"issuer":{"id":85102,"kind":"organization","name":"LUMOS PHARMA, INC.","symbol":"(LUMO)"},"owners":[{"id":85104,"kind":"person","name":"Schuchart Aaron","position":1,"cik":"0001709258","reported_name":"Schuchart Aaron","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Business Officer"}}],"security":"Common Stock","published_at":"2021-08-13T16:32:42.000Z","date":"2021-08-12","kind":"purchase","acquired":true,"shares":1700,"price":7.42,"value":12614.0,"ownership":{"direct":true},"footnotes":[{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F1","text":"Includes 695 restricted stock units (\"RSUs\") previously reported as holdings of the Reporting Person granted under the Issuer's 2009 Equity Incentive Plan (the \"Plan\").  The RSUs will vest, and shares will be delivered to the Reporting Person in a series of four successive annual installments with the next installment occurring on February 1, 2022, provided in each case that the Reporting Person's continuous service to the Issuer has not been terminated as defined in or as determined under the Plan."}],"balance_after":3037,"source":{"system":"sec-edgar","filing":"0001126234-21-000113","document":"wf-form4_162888671669667.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1126234/000112623421000113/wf-form4_162888671669667.xml","form_type":"4"}},{"id":2604053,"issuer":{"id":85102,"kind":"organization","name":"LUMOS PHARMA, INC.","symbol":"(LUMO)"},"owners":[{"id":85104,"kind":"person","name":"Schuchart Aaron","position":1,"cik":"0001709258","reported_name":"Schuchart Aaron","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Business Officer"}}],"security":"Common Stock","published_at":"2021-08-13T16:32:42.000Z","date":"2021-08-11","kind":"purchase","acquired":true,"shares":300,"price":7.35,"value":2205.0,"ownership":{"direct":true},"footnotes":[{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F1","text":"Includes 695 restricted stock units (\"RSUs\") previously reported as holdings of the Reporting Person granted under the Issuer's 2009 Equity Incentive Plan (the \"Plan\").  The RSUs will vest, and shares will be delivered to the Reporting Person in a series of four successive annual installments with the next installment occurring on February 1, 2022, provided in each case that the Reporting Person's continuous service to the Issuer has not been terminated as defined in or as determined under the Plan."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Includes 109 shares acquired under the Lumos Pharma, Inc. 2010 Employee Stock Purchase Plan on June 30, 2021."}],"balance_after":1337,"source":{"system":"sec-edgar","filing":"0001126234-21-000113","document":"wf-form4_162888671669667.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1126234/000112623421000113/wf-form4_162888671669667.xml","form_type":"4"}},{"id":2684025,"issuer":{"id":85102,"kind":"organization","name":"LUMOS PHARMA, INC.","symbol":"(LUMO)"},"owners":[{"id":85104,"kind":"person","name":"Schuchart Aaron","position":1,"cik":"0001709258","reported_name":"Schuchart Aaron","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Business Officer"}}],"security":"Stock Option (Right to Buy)","published_at":"2021-06-03T16:52:33.000Z","date":"2021-06-01","kind":"grant","acquired":true,"shares":7805,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Grant to the Reporting Person of a stock option under the Issuer's 2009 Equity Incentive Plan (the \"Plan\"). The option vests and becomes exercisable in a series of 48 successive equal monthly installments beginning on July 1, 2021, provided that at the relevant vesting dates the Reporting Person's continuous service to the Issuer has not been terminated as defined in or as determined under the Plan. The option expires ten years after the date of grant."}],"balance_after":7805,"derivative":{"exercise_price":10.13,"expiration_date":"2031-05-31","underlying":"Common Stock","underlying_shares":7805},"source":{"system":"sec-edgar","filing":"0001126234-21-000088","document":"wf-form4_162275349099019.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1126234/000112623421000088/wf-form4_162275349099019.xml","form_type":"4"}},{"id":3623362,"issuer":{"id":2649,"kind":"organization","name":"Spyre Therapeutics, Inc.","symbol":"SYRE"},"owners":[{"id":85104,"kind":"person","name":"Schuchart Aaron","position":1,"cik":"0001709258","reported_name":"Schuchart Aaron","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Business Officer"}}],"security":"Employee Stock Option (right to buy)","published_at":"2019-03-01T17:09:04.000Z","date":"2019-02-28","kind":"grant","acquired":true,"shares":60000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The stock option vests and becomes exercisable in 48 equal monthly installments beginning on March 28, 2019, until such time as the option is 100% vested, subject to the continuing employment of the Reporting Person on each vesting date."}],"balance_after":60000,"derivative":{"exercise_price":8.36,"expiration_date":"2029-02-27","underlying":"Common Stock","underlying_shares":60000},"source":{"system":"sec-edgar","filing":"0001567619-19-005836","document":"doc1.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1709258/000156761919005836/doc1.xml","form_type":"4"}},{"id":3805616,"issuer":{"id":2649,"kind":"organization","name":"Spyre Therapeutics, Inc.","symbol":"SYRE"},"owners":[{"id":85104,"kind":"person","name":"Schuchart Aaron","position":1,"cik":"0001709258","reported_name":"Schuchart Aaron","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Business Officer"}}],"security":"Common Stock","published_at":"2018-09-28T17:11:26.000Z","date":"2018-09-27","kind":"sale","acquired":false,"shares":5900,"price":9.5,"value":56050.0,"ownership":{"direct":true},"balance_after":2500,"source":{"system":"sec-edgar","filing":"0001567619-18-003282","document":"doc1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1709258/000156761918003282/doc1.xml","form_type":"4"}},{"id":3805615,"issuer":{"id":2649,"kind":"organization","name":"Spyre Therapeutics, Inc.","symbol":"SYRE"},"owners":[{"id":85104,"kind":"person","name":"Schuchart Aaron","position":1,"cik":"0001709258","reported_name":"Schuchart Aaron","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Business Officer"}}],"security":"Common Stock","published_at":"2018-09-28T17:11:26.000Z","date":"2018-09-27","kind":"sale","acquired":false,"shares":100,"price":9.55,"value":955.0,"ownership":{"direct":true},"balance_after":8400,"source":{"system":"sec-edgar","filing":"0001567619-18-003282","document":"doc1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1709258/000156761918003282/doc1.xml","form_type":"4"}},{"id":3837267,"issuer":{"id":2649,"kind":"organization","name":"Spyre Therapeutics, Inc.","symbol":"SYRE"},"owners":[{"id":85104,"kind":"person","name":"Schuchart Aaron","position":1,"cik":"0001709258","reported_name":"Schuchart Aaron","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Business Officer"}}],"security":"Employee Stock Option (right to buy)","published_at":"2018-08-21T16:24:28.000Z","date":"2018-08-17","kind":"exercise","acquired":false,"shares":8500,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The stock option vested and became exercisable as to 1/4th of the shares subject to the option on May 22, 2018, and thereafter vests and becomes exercisable as to 1/48th of the shares in equal monthly installments, until such time as the option is 100% vested, subject to the continuing employment of the Reporting Person on each vesting date."}],"balance_after":91500,"derivative":{"exercise_price":3.5,"expiration_date":"2027-06-15","underlying":"Common Stock","underlying_shares":8500},"source":{"system":"sec-edgar","filing":"0001567619-18-001566","document":"doc1.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1709258/000156761918001566/doc1.xml","form_type":"4"}},{"id":3837266,"issuer":{"id":2649,"kind":"organization","name":"Spyre Therapeutics, Inc.","symbol":"SYRE"},"owners":[{"id":85104,"kind":"person","name":"Schuchart Aaron","position":1,"cik":"0001709258","reported_name":"Schuchart Aaron","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Business Officer"}}],"security":"Common Stock","published_at":"2018-08-21T16:24:28.000Z","date":"2018-08-17","kind":"exercise","acquired":true,"shares":8500,"price":3.5,"value":29750.0,"ownership":{"direct":true},"balance_after":8500,"source":{"system":"sec-edgar","filing":"0001567619-18-001566","document":"doc1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1709258/000156761918001566/doc1.xml","form_type":"4"}},{"id":4040703,"issuer":{"id":2649,"kind":"organization","name":"Spyre Therapeutics, Inc.","symbol":"SYRE"},"owners":[{"id":85104,"kind":"person","name":"Schuchart Aaron","position":1,"cik":"0001709258","reported_name":"Schuchart Aaron","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Business Officer"}}],"security":"Employee Stock Option (right to buy)","published_at":"2018-02-22T18:22:24.000Z","date":"2018-02-20","kind":"grant","acquired":true,"shares":20000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The stock option vests and becomes exercisable in 48 equal monthly installments beginning on March 20, 2018, until such time as the option is 100% vested, subject to the continuing employment of the Reporting Person on each vesting date."}],"balance_after":20000,"derivative":{"exercise_price":6.31,"expiration_date":"2028-02-19","underlying":"Common Stock","underlying_shares":20000},"source":{"system":"sec-edgar","filing":"0001140361-18-009664","document":"doc1.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1709258/000114036118009664/doc1.xml","form_type":"4"}},{"id":4225629,"issuer":{"id":2649,"kind":"organization","name":"Spyre Therapeutics, Inc.","symbol":"SYRE"},"owners":[{"id":85104,"kind":"person","name":"Schuchart Aaron","position":1,"cik":"0001709258","reported_name":"Schuchart Aaron","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Business Officer"}}],"security":"Employee Stock Option (right to buy)","published_at":"2017-08-24T18:02:54.000Z","date":"2017-08-22","kind":"grant","acquired":true,"shares":10000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The stock option vests and becomes exercisable as to 50% of the shares subject to the option on August 22, 2018, an additional 30% of the shares subject to the option on August 22, 2019, and the remaining 20% of the shares subject to the option on August 22, 2020, subject to the continuing employment of the Reporting Person on each vesting date."}],"balance_after":10000,"derivative":{"exercise_price":3.1,"expiration_date":"2027-08-21","underlying":"Common Stock","underlying_shares":10000},"source":{"system":"sec-edgar","filing":"0001140361-17-033207","document":"doc1.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1709258/000114036117033207/doc1.xml","form_type":"4"}},{"id":4276230,"issuer":{"id":2649,"kind":"organization","name":"Spyre Therapeutics, Inc.","symbol":"SYRE"},"owners":[{"id":85104,"kind":"person","name":"Schuchart Aaron","position":1,"cik":"0001709258","reported_name":"Schuchart Aaron","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Business Officer"}}],"security":"Employee Stock Option (right to buy)","published_at":"2017-06-20T17:06:51.000Z","date":"2017-06-16","kind":"grant","acquired":true,"shares":100000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The stock option vests and becomes exercisable as to 1/4th of the shares subject to the option on May 22, 2018, and thereafter vests as to 1/48th of the shares in equal monthly installments, until such time as the option is 100% vested, subject to the continuing employment of the Reporting Person on each vesting date."}],"balance_after":100000,"derivative":{"exercise_price":3.5,"expiration_date":"2027-06-15","underlying":"Common Stock","underlying_shares":100000},"source":{"system":"sec-edgar","filing":"0001140361-17-025613","document":"doc1.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1709258/000114036117025613/doc1.xml","form_type":"4"}}]}